Key regions: United States, Spain, Europe, Thailand, Canada
Turkey has seen a significant growth in the Pharmaceutical Cannabis market, reflecting a global trend towards the acceptance and legalization of medical cannabis products.
Customer preferences: Customers in Turkey are increasingly seeking alternative and natural remedies for various health conditions, driving the demand for pharmaceutical cannabis products. The shift towards organic and plant-based solutions is influencing consumer preferences in the pharmaceutical industry.
Trends in the market: One notable trend in the Turkish Pharmaceutical Cannabis market is the increasing number of partnerships and collaborations between local pharmaceutical companies and international cannabis producers. This trend is not only facilitating the entry of foreign expertise and technology into the market but also expanding the product offerings available to Turkish consumers. Additionally, the growing acceptance of medical cannabis for treating a range of conditions is leading to an expansion in the variety of products available in the market.
Local special circumstances: Turkey's unique geographical location and climate provide ideal conditions for cultivating cannabis, making it a potential hub for cannabis production in the region. The country's rich history of herbal medicine and traditional remedies also contributes to the growing acceptance of pharmaceutical cannabis products among the population. Furthermore, the government's efforts to regulate and legalize the medical use of cannabis have created a conducive environment for market growth.
Underlying macroeconomic factors: The Pharmaceutical Cannabis market in Turkey is also influenced by broader macroeconomic factors such as changing regulatory environments, evolving healthcare policies, and increasing investment in the healthcare sector. The government's push towards healthcare modernization and the adoption of innovative treatments are creating opportunities for pharmaceutical cannabis companies to expand their operations in the country. Additionally, Turkey's strategic position as a bridge between Europe and Asia positions it as a potential key player in the global cannabis market.
Data coverage:
Data encompasses B2B and B2C enterprises. Figures are based on companies' revenues, funding values and global consumer survey data. Revenues include retail, sales and taxes.Modeling approach / Market size:
Market sizes are determined by a Top-Down approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports, third-party data. Next, we use relevant key market indicators and data from country-specific associations such as tobacco spending per capita, medical product spending per capita, consumer spending and consumer spending for recreation purposes, population. This data helps us to estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function.Additional Notes:
The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
